Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £15,654,150 of indicative cost of Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 29.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £1,809,900 |
| The Walton Centre Nhs Foundation Trust | £1,232,550 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,154,700 |
| University Hospitals Dorset Nhs Ft | £950,400 |
| South Tyneside And Sunderland Nhs Ft | £923,850 |
| Sheffield Teaching Hospitals Nhs Trust | £635,400 |
| York Teaching Hospital Nhs Ft | £564,300 |
| East Sussex Healthcare Nhs Trust | £555,300 |
| Western Sussex Hospitals Nhs Found Trust | £547,200 |
| Ashford & St Peter's Hospitals Nhs Ft | £503,550 |
The primary-care picture
Galcanezumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Galcanezumab medicine page.